Literature DB >> 25013393

Risk assessment in Crohn's disease.

Marla C Dubinsky1.   

Abstract

Entities:  

Year:  2014        PMID: 25013393      PMCID: PMC4080877     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  5 in total

1.  Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.

Authors:  Marla Cindy Dubinsky
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

2.  Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease.

Authors:  Corey A Siegel; Lori S Siegel; Jeffrey S Hyams; Subra Kugathasan; James Markowitz; Joel R Rosh; Neal Leleiko; David R Mack; Wallace Crandall; Jonathan Evans; David J Keljo; Anthony R Otley; Maria Oliva-Hemker; Sharmayne Farrior; Christine R Langton; Iwona T Wrobel; Ghassan Wahbeh; J Antonio Quiros; Gary Silber; Ron J Bahar; Bruce E Sands; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

3.  A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease.

Authors:  Elaheh Vahabnezhad; Shervin Rabizadeh; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

Review 4.  Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease.

Authors:  Parambir S Dulai; Corey A Siegel; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

5.  Multidimensional prognostic risk assessment identifies association between IL12B variation and surgery in Crohn's disease.

Authors:  Marla C Dubinsky; Subra Kugathasan; Soonil Kwon; Talin Haritunians; Iwona Wrobel; Ghassan Wahbeh; Antonio Quiros; Ron Bahar; Gary Silber; Sharmayne Farrior; Michael Stephens; Nick Teleten; Deepa Panikkath; Andrew Ippoliti; Eric Vasiliauskas; Phillip Fleshner; Chadwick Williams; Carol Landers; Jerome I Rotter; Stephan R Targan; Kent D Taylor; Dermot P B McGovern
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.